ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
LLNL, Ampera partner to develop thorium-based TRISO fuel
Lawrence Livermore National Laboratory has formed a strategic partnership with Ampera to develop the company’s nuclear fuel concept through a project named THUNDER, for Thorium Unimodal Droplet Ejection for Reactors.
The focus of THUNDER is fabricating TRISO made with kernels of thorium rather than the usual uranium. LLNL and Ampera will evaluate and optimize liquid metal–jetting technology to produce highly uniform, spherical kernels of thorium-232 for later processing into TRISO fuel.
Hungyuan B. Liu, Robert M. Brugger
Nuclear Technology | Volume 108 | Number 2 | November 1994 | Pages 151-156
Technical Paper | Fission Reactor | doi.org/10.13182/NT94-A35026
Articles are hosted by Taylor and Francis Online.
Convenient, economical epithermal neutron beams will be needed in the future for boron neutron capture therapy (BNCT). We studied two concepts for producing epithermal neutron beams with low-power reactors. The first design is a 100-kW reactor with a 235U fission plate placed outside the reflector region, plus an Al/Al2O3 moderator assembly. The beam, which is directed forward, delivers a flux of epithermal neutrons of 0.8 × 109 n/cm2·s and a fast neutron dose of 4.4 × 10−11 cGy·cm2/nepi. The second design is based on a slab reactor plus a similar Al/Al2O3 moderator assembly. With an operating power of 50 kW, the beam has an intensity of 1.4 × 109 n/cm2.s and a fast neutron dose of 4.6 × 10−11 cGy·cm2/nepi; this beam also is directed forward. These epithermal neutron beams should be acceptable for BNCT; a treatment could be completed in ∼1 h, and the fast neutron dose to the skin would not be the limiting dose. Such small reactors should be practicable in a hospital location.